Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL289 Target Snapshot

Cytochrome P450 2D6 · SINGLE PROTEIN · Homo sapiens

27,662Compounds
3,314Assays
103Approved Drugs
9,497.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P10635. Use UniProt P10635 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P10635 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome P450 2D6 as ChEMBL target CHEMBL289, mapped to UniProt P10635. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome P450 2D6
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL289
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P10635
Cytochrome P450 2D6
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome P450 2D6 is the right protein anchor across sources, using UniProt P10635 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCytochrome P450 2D6
UniProt AccessionP10635
Component TypeProtein
Sequence Length497 aa

Cytochrome P450 2D6

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome P450 2D6, mapped to UniProt P10635. Sequence length is 497 aa.

Mapped IDP10635
Review nameCytochrome P450 2D6
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

103
Approved
25
Phase III
48
Phase II
9
Phase I
Assay Mix

Activity Type Distribution

IC508,456.0
KI1,013.0
EC5026.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL180672 10.35 IC50 0.045 Preclinical
CHEMBL382741 10.0 IC50 0.1 Preclinical
CHEMBL220360 9.23 IC50 0.59 Clinical
CHEMBL157101 8.73 IC50 1.86 Approved
CHEMBL1091778 8.7 IC50 2.0 Preclinical
CHEMBL1294 8.7 IC50 2.0 Approved
CHEMBL538632 8.59 IC50 2.6 Preclinical
CHEMBL4857395 8.52 IC50 3.0 Preclinical
CHEMBL1204009 8.52 IC50 3.0 Preclinical
CHEMBL539650 8.4 IC50 4.0 Preclinical
Distribution

pChEMBL Value Distribution

864
5.0
549
5.5
414
6.0
216
6.5
148
7.0
58
7.5
32
8.0
6
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

QUININE
CHEMBL170
Approved 2005
DULOXETINE
CHEMBL1175
Approved 2004
CINACALCET
CHEMBL1201284
Approved 2004
LEVOBUPIVACAINE
CHEMBL1201193
Approved 1999
CELECOXIB
CHEMBL118
Approved 1998
MIBEFRADIL
CHEMBL45816
Approved 1997
BUTENAFINE
CHEMBL990
Approved 1996
AZELASTINE
CHEMBL639
Approved 1996
CISAPRIDE
CHEMBL1729
Approved 1993
TACRINE
CHEMBL95
Approved 1993
PAROXETINE HYDROCHLORIDE
CHEMBL6067650
Approved 1992
PAROXETINE
CHEMBL490
Approved 1992
TERBINAFINE
CHEMBL822
Approved 1992
PERGOLIDE
CHEMBL531
Approved 1988
OXICONAZOLE
CHEMBL1262
Approved 1988
FLUOXETINE
CHEMBL41
Approved 1987
OXYMETAZOLINE
CHEMBL762
Approved 1986
SULCONAZOLE
CHEMBL1221
Approved 1985
NALTREXONE
CHEMBL19019
Approved 1984
LABETALOL
CHEMBL429
Approved 1984
DEXTROMETHORPHAN
CHEMBL52440
Approved 1982
GENTIAN VIOLET
CHEMBL64894
Approved 1982
ECONAZOLE
CHEMBL808
Approved 1982
AMODIAQUINE
CHEMBL682
Approved 1982
KETOCONAZOLE
CHEMBL157101
Approved 1981
METOCLOPRAMIDE
CHEMBL86
Approved 1979
CLOTRIMAZOLE
CHEMBL104
Approved 1975
MICONAZOLE
CHEMBL91
Approved 1974
PERHEXILINE
CHEMBL75880
Approved 1974
PYRILAMINE
CHEMBL511
Approved 1973
BUPIVACAINE HYDROCHLORIDE
CHEMBL1200396
Approved 1972
DIPHENIDOL
CHEMBL936
Approved 1967
DOXAPRAM
CHEMBL1754
Approved 1965
NORTRIPTYLINE
CHEMBL445
Approved 1964
QUINIDINE SULFATE
CHEMBL3707183
Approved 1962
PHENELZINE
CHEMBL1089
Approved 1961
ORPHENADRINE
CHEMBL900
Approved 1957
PERPHENAZINE
CHEMBL567
Approved 1957
PROCHLORPERAZINE
CHEMBL728
Approved 1956
PROMAZINE
CHEMBL564
Approved 1956
QUINIDINE
CHEMBL1294
Approved 1950
METHYLERGONOVINE
CHEMBL1201356
Approved 1946
Source · ChEMBL 36 via Core Engine